Chimerix
CMRX64
$0.85arrow_drop_down3.18%-$0.02
Penny Stock
CMRX64
$0.85
arrow_drop_down3.18%Performance History
| Key Stats | |
|---|---|
| Open | $0.89 |
| Prev. Close | $0.88 |
| EPS | -0.96 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $77.08M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 0.84 | 0.89 |
| 52 Week Range | 0.75 | 1.30 |
| Ratios | |
|---|---|
| Revenue | - |
| EBITDA Margin % | - |
| EPS | -0.96 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Chimerix (CMRX)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Michael T. Andriole M.B.A.
- Headquarters
- Durham
- Employees
- 89
- Exchange
- NASDAQ
Keep an eye on Chimerix
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Chimerix 's (CMRX) price per share?
The current price per share for Chimerix (CMRX) is $0.85. The stock has seen a price change of -$0.03 recently, indicating a -3.18% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Chimerix (CMRX)?
For Chimerix (CMRX), the 52-week high is $1.3, which is 52.58% from the current price. The 52-week low is $0.75, the current price is 13.6% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Chimerix (CMRX) a growth stock?
Chimerix (CMRX) has shown an average price growth of 0.41% over the past three years. It has received a score of 8 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Chimerix as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Chimerix (CMRX) stock price performance year to date (YTD)?
As of the latest data, Chimerix (CMRX) has a year-to-date price change of -11.25%. Over the past month, the stock has experienced a price change of -18.86%. Over the last three months, the change has been -4.27%. Over the past six months, the figure is -11.25%. Looking at a longer horizon, the five-year price change stands at -63.59%.
help
Is Chimerix (CMRX) a profitable company?
Chimerix (CMRX) has a net income of -$82.1M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -17.7K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $323K. Operating income is noted at -$93.06M. Furthermore, the EBITDA is -$94.63M.
help
What is the market capitalization of Chimerix (CMRX)?
Chimerix (CMRX) has a market capitalization of $77.09M. The average daily trading volume is 157.07K, indicating the stock's liquidity and investor engagement.
News
CALENDAR OF EVENTS
CONFERENCE CALLS/ WEBCASTS
4/24/2024Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024
CHANGES IN COMPANY'S OWN SHARES
4/16/2024Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CALENDAR OF EVENTS
CONFERENCE CALLS/ WEBCASTS
2/22/2024Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024
DIRECTORS AND OFFICERS
12/29/2023Chimerix Appoints Lisa Decker to Board of Directors
DIRECTORS AND OFFICERS
12/4/2023Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer
REGULATORY INFORMATION
11/24/2023Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)